Literature DB >> 20456908

Failure to achieve clinical improvement despite graft patency in patients undergoing infrainguinal lower extremity bypass for critical limb ischemia.

Jessica P Simons1, Philip P Goodney, Brian W Nolan, Jack L Cronenwett, Louis M Messina, Andres Schanzer.   

Abstract

OBJECTIVE: Studies of infrainguinal lower extremity bypass for critical limb ischemia (CLI) have traditionally emphasized outcomes of patency, limb salvage, and death. Because functional outcomes are equally important, our objectives were to describe the proportion of CLI patients who did not achieve symptomatic improvement 1 year after bypass, despite having patent grafts, and identify preoperative factors associated with this outcome.
METHODS: The prospectively collected Vascular Study Group of Northern New England database was used to identify all patients with elective infrainguinal lower extremity bypass for CLI (2003 to 2007) for whom long-term follow-up data were available. The primary composite study end point was clinical failure at 1 year after bypass, defined as amputation or persistent or worsened ischemic symptoms (rest pain or tissue loss), despite a patent graft. Variables identified on univariate screening (inclusion threshold, P < .20) were included in a multivariable logistic regression model to identify independent predictors.
RESULTS: Long-term follow-up data were available for 1012 patients who underwent infrainguinal bypasses for CLI, of which 788 (78%) remained patent at 1 year. Of these, 79 (10%) met criteria for the composite end point of clinical failure: 21 (2.7%) for major amputations and 58 (7.4%) for persistent rest pain or tissue loss. In multivariable analysis, significant predictors of clinical failure included dialysis dependence (odds ratio [OR], 3.74; 95% confidence interval [CI], 1.84-7.62; P < .001) and preoperative inability to ambulate independently (OR, 2.17; 95% CI, 1.26-3.73; P = .005). A history of coronary artery bypass graft or percutaneous coronary intervention was protective (OR, 0.52; 95% CI, 0.29-0.93; P = .03).
CONCLUSIONS: After infrainguinal lower extremity bypass for CLI, 10% of patients with a patent graft did not achieve clinical improvement at 1 year. Preoperative identification of this specific patient subgroup remains challenging. To improve surgical decision making and the overall care of CLI patients, further emphasis needs to be placed on functional outcomes in addition to traditional surgical end points. Copyright (c) 2010 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20456908      PMCID: PMC5240817          DOI: 10.1016/j.jvs.2010.01.083

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  22 in total

1.  A meta-analysis of infrainguinal arterial reconstruction in patients with end-stage renal disease.

Authors:  M Albers; M Romiti; C A Bragança Pereira; R L Fonseca; M da Silva Júnior
Journal:  Eur J Vasc Endovasc Surg       Date:  2001-10       Impact factor: 7.069

2.  Factors associated with limb loss despite a patent infrainguinal bypass graft.

Authors:  C G Carsten; S M Taylor; E M Langan; M M Crane
Journal:  Am Surg       Date:  1998-01       Impact factor: 0.688

3.  Trends in the presentation and surgical management of the acute diabetic foot.

Authors:  D J Adam; S Raptis; R A Fitridge
Journal:  Eur J Vasc Endovasc Surg       Date:  2005-07-14       Impact factor: 7.069

4.  Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia.

Authors:  Louis L Nguyen; Gregory L Moneta; Michael S Conte; Dennis F Bandyk; Alexander W Clowes; B Lynn Seely
Journal:  J Vasc Surg       Date:  2006-11       Impact factor: 4.268

5.  Does preferential use of endovascular interventions by vascular surgeons improve limb salvage, control of symptoms, and survival of patients with critical limb ischemia?

Authors:  Hasan H Dosluoglu; Maureen S O'Brien-Irr; Jim Lukan; Linda M Harris; Maciej L Dryjski; Gregory S Cherr
Journal:  Am J Surg       Date:  2006-11       Impact factor: 2.565

6.  Primary cryoplasty therapy provides durable support for limb salvage in critical limb ischemia patients with infrapopliteal lesions: 12-month follow-up results from the BTK Chill Trial.

Authors:  Tony S Das; Thomas McNamara; Bruce Gray; Gino J Sedillo; Brian R Turley; Kenneth Kollmeyer; Michael Rogoff; John E Aruny
Journal:  J Endovasc Ther       Date:  2009-04       Impact factor: 3.487

7.  Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia.

Authors:  Andres Schanzer; Philip P Goodney; Youfu Li; Mohammad Eslami; Jack Cronenwett; Louis Messina; Michael S Conte
Journal:  J Vasc Surg       Date:  2009-07-22       Impact factor: 4.268

8.  Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data.

Authors:  Andres Schanzer; Jessica Mega; Judith Meadows; Russell H Samson; Dennis F Bandyk; Michael S Conte
Journal:  J Vasc Surg       Date:  2008-12       Impact factor: 4.268

9.  Failure of foot salvage in patients with end-stage renal disease after surgical revascularization.

Authors:  B L Johnson; M H Glickman; D F Bandyk; G E Esses
Journal:  J Vasc Surg       Date:  1995-09       Impact factor: 4.268

10.  Redo infrainguinal bypass: factors predicting patency and limb salvage.

Authors:  Peter J Rossi; Christopher L Skelly; Shari L Meyerson; Hisham S Bassiouny; Daniel Katz; Lewis B Schwartz; James F McKinsey; Bruce L Gewertz; Tina R Desai
Journal:  Ann Vasc Surg       Date:  2003-09-10       Impact factor: 1.466

View more
  20 in total

1.  Variation in the use of lower extremity vascular procedures for critical limb ischemia.

Authors:  Philip P Goodney; Lori L Travis; Brahmajee K Nallamothu; Kerianne Holman; Bjoern Suckow; Peter K Henke; F Lee Lucas; David C Goodman; John D Birkmeyer; Elliott S Fisher
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-12-06

2.  Functional outcomes after lower extremity revascularization in nursing home residents: a national cohort study.

Authors:  Lawrence Oresanya; Shoujun Zhao; Siqi Gan; Brant E Fries; Philip P Goodney; Kenneth E Covinsky; Michael S Conte; Emily Finlayson
Journal:  JAMA Intern Med       Date:  2015-06       Impact factor: 21.873

3.  Defining utility and predicting outcome of cadaveric lower extremity bypass grafts in patients with critical limb ischemia.

Authors:  Catherine K Chang; Salvatore T Scali; Robert J Feezor; Adam W Beck; Alyson L Waterman; Thomas S Huber; Scott A Berceli
Journal:  J Vasc Surg       Date:  2014-07-16       Impact factor: 4.268

4.  Early-phase wound healing and long-term outcomes of a selective endovascular-first approach for treating Rutherford 5 critical limb ischemia with infrainguinal lesions.

Authors:  Kentaro Inoue; Toshihiro Onohara; Keita Mikasa; Tadashi Furuyama
Journal:  Surg Today       Date:  2016-04-18       Impact factor: 2.549

5.  Objective measurement of lower extremity function and quality of life after surgical revascularization for critical lower extremity ischemia.

Authors:  Gregory J Landry; Nick O Esmonde; Jason R Lewis; Amir F Azarbal; Timothy K Liem; Erica L Mitchell; Gregory L Moneta
Journal:  J Vasc Surg       Date:  2014-03-07       Impact factor: 4.268

6.  Association of arterial calcification with chronic limb ischemia in patients with peripheral artery disease.

Authors:  Sara L Zettervall; Andre P Marshall; Paul Fleser; Raul J Guzman
Journal:  J Vasc Surg       Date:  2017-09-01       Impact factor: 4.268

7.  Blood transfusion for lower extremity bypass is associated with increased wound infection and graft thrombosis.

Authors:  Tze-Woei Tan; Alik Farber; Naomi M Hamburg; Robert T Eberhardt; Denis Rybin; Gheorghe Doros; Jens Eldrup-Jorgensen; Philip P Goodney; Jack L Cronenwett; Jeffrey A Kalish
Journal:  J Am Coll Surg       Date:  2013-03-25       Impact factor: 6.113

8.  Critical limb ischemia.

Authors:  Andres Schanzer; Michael S Conte
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-04-14

9.  Regional intensity of vascular care and lower extremity amputation rates.

Authors:  Philip P Goodney; Kerianne Holman; Peter K Henke; Lori L Travis; Justin B Dimick; Therese A Stukel; Elliott S Fisher; John D Birkmeyer
Journal:  J Vasc Surg       Date:  2013-02-01       Impact factor: 4.268

Review 10.  Treatment of infrapopliteal critical limb ischemia in 2013: the wound perfusion approach.

Authors:  Matthew C Bunte; Mehdi H Shishehbor
Journal:  Curr Cardiol Rep       Date:  2013-06       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.